The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.27757. At the end of 2023 the company had a P/S ratio of 5.47.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.47 | 2.71% |
2022 | 5.32 | 9.15% |
2021 | 4.88 | -7.35% |
2020 | 5.26 | -13.73% |
2019 | 6.10 | 18.24% |
2018 | 5.16 | -6.58% |
2017 | 5.52 | 16.78% |
2016 | 4.73 | -16.27% |
2015 | 5.65 | -6.41% |
2014 | 6.04 | 30.98% |
2013 | 4.61 | 22.07% |
2012 | 3.78 | 4.54% |
2011 | 3.61 | 6.26% |
2010 | 3.40 | -11.58% |
2009 | 3.84 | -4.61% |
2008 | 4.03 | 17.93% |
2007 | 3.42 | -38.78% |
2006 | 5.58 | -28.11% |
2005 | 7.77 | 1.36% |
2004 | 7.66 | -19.29% |
2003 | 9.49 | -17.08% |
2002 | 11.4 | -23.23% |
2001 | 14.9 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.92 | -25.79% | ๐บ๐ธ USA |
Pfizer PFE | 2.63 | -50.15% | ๐บ๐ธ USA |
AbbVie ABBV | 5.27 | -0.11% | ๐บ๐ธ USA |
Eli Lilly LLY | 21.6 | 310.07% | ๐บ๐ธ USA |
Biogen BIIB | 3.26 | -38.30% | ๐บ๐ธ USA |
Gilead Sciences GILD | 3.01 | -42.92% | ๐บ๐ธ USA |
Illumina ILMN | 4.41 | -16.47% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 1.97 | -62.71% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2.32 | -56.10% | ๐ฌ๐ง UK |